Parsons, Anna <br/><br/>
Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.  [electronic resource] 

 -  Obstetrics and gynecology  Feb 2003 
 - 346-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0029-7844 
<br/><br/><label>Standard No.: </label>10.1016/s0029-7844(02)02726-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravaginal<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Atrophy--drug therapy<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Estrogens, Conjugated (USP)--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Middle Aged<br/>Postmenopause--drug effects<br/>Probability<br/>Raloxifene Hydrochloride--administration & dosage<br/>Reference Values<br/>Sensitivity and Specificity<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Vagina--pathology<br/>Vaginal Creams, Foams, and Jellies--therapeutic use<br/>Vaginal Diseases--drug therapy